These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11432696)

  • 21. A novel antipsychotic, perospirone, has antiserotonergic and antidopaminergic effects in human brain: findings from neuroendocrine challenge tests.
    Iwakawa M; Terao T; Soya A; Kojima H; Inoue Y; Ueda N; Yoshimura R; Nakamura J
    Psychopharmacology (Berl); 2004 Nov; 176(3-4):407-11. PubMed ID: 15160263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonergic 'vulnerability' in affective disorder: a study of the tryptophan depletion test and relationships between peripheral and central serotonin indexes in citalopram-responders.
    Aberg-Wistedt A; Hasselmark L; Stain-Malmgren R; Apéria B; Kjellman BF; Mathé AA
    Acta Psychiatr Scand; 1998 May; 97(5):374-80. PubMed ID: 9611088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI.
    Zhang Y; Damjanoska KJ; Carrasco GA; Dudas B; D'Souza DN; Tetzlaff J; Garcia F; Hanley NR; Scripathirathan K; Petersen BR; Gray TS; Battaglia G; Muma NA; Van de Kar LD
    J Neurosci; 2002 Nov; 22(21):9635-42. PubMed ID: 12417689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys.
    Aloi JA; Insel TR; Mueller EA; Murphy DL
    Life Sci; 1984 Apr; 34(14):1325-31. PubMed ID: 6708733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonergic regulation of prolactin and growth hormone secretion in man.
    Lewis DA; Sherman BM
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):152-7. PubMed ID: 4060968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Escitalopram prolonged fear induced by simulated public speaking and released hypothalamic-pituitary-adrenal axis activation.
    Garcia-Leal C; Del-Ben CM; Leal FM; Graeff FG; Guimarães FS
    J Psychopharmacol; 2010 May; 24(5):683-94. PubMed ID: 19251828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of 5-HT1a and 5-HT2a receptors in attention and motor control: a mechanistic study in healthy volunteers.
    Wingen M; Kuypers KP; Ramaekers JG
    Psychopharmacology (Berl); 2007 Feb; 190(3):391-400. PubMed ID: 17124621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 5-HT3 antagonist, BRL 46470 does not attenuate m-chlorophenylpiperazine (mCPP)-induced changes in human volunteers.
    Silverstone PH; Cowen PJ
    Biol Psychiatry; 1994 Sep; 36(5):309-16. PubMed ID: 7993957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute hormonal changes after IV citalopram and treatment response in OCD.
    Corregiari FM; Gattaz WF; Bernik M
    Psychopharmacology (Berl); 2007 Sep; 193(4):487-94. PubMed ID: 17492272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analgesic effect of amitriptyline in chronic tension-type headache is not directly related to serotonin reuptake inhibition.
    Ashina S; Bendtsen L; Jensen R
    Pain; 2004 Mar; 108(1-2):108-14. PubMed ID: 15109513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood.
    Riedel WJ; Klaassen T; Griez E; Honig A; Menheere PP; van Praag HM
    Neuropsychopharmacology; 2002 Mar; 26(3):358-67. PubMed ID: 11850150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans.
    Mueller EA; Murphy DL; Sunderland T
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1179-84. PubMed ID: 4055985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of pindolol on the prolactin response to d-fenfluramine.
    Park SB; Cowen PJ
    Psychopharmacology (Berl); 1995 Apr; 118(4):471-4. PubMed ID: 7568634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.
    Millan MJ; Veiga S; Girardon S; Brocco M
    Psychopharmacology (Berl); 2003 Aug; 168(4):397-409. PubMed ID: 12721776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Citalopram-induced hypophagia is enhanced by blockade of 5-HT(1A) receptors: role of 5-HT(2C) receptors.
    Grignaschi G; Invernizzi RW; Fanelli E; Fracasso C; Caccia S; Samanin R
    Br J Pharmacol; 1998 Aug; 124(8):1781-7. PubMed ID: 9756397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine evidence for reduced serotonergic neurotransmission during heavy drinking.
    Balldin J; Berggren U; Engel J; Eriksson M
    Alcohol Clin Exp Res; 1994 Aug; 18(4):822-5. PubMed ID: 7978090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of abdominally obese men with a serotonin reuptake inhibitor: a pilot study.
    Ljung T; Ahlberg AC; Holm G; Friberg P; Andersson B; Eriksson E; Björntorp P
    J Intern Med; 2001 Sep; 250(3):219-24. PubMed ID: 11555126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo drug action of tandospirone at 5-HT1A receptor examined using positron emission tomography and neuroendocrine response.
    Nakayama T; Suhara T; Okubo Y; Ichimiya T; Yasuno F; Maeda J; Takano A; Saijo T; Suzuki K
    Psychopharmacology (Berl); 2002 Dec; 165(1):37-42. PubMed ID: 12474116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone.
    Markianos M; Hatzimanolis J; Lykouras L
    Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used.
    Lucas G; De Deurwaerdère P; Caccia S; Umberto Spampinato
    Neuropharmacology; 2000 Apr; 39(6):1053-63. PubMed ID: 10727716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.